The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
LONDON / WAM
Biopharmaceutical company, AstraZeneca, said on Thursday it had received the first agreements to supply at least 400 million doses of the Covid-19 vaccine it is developing with the University of Oxford, reported Reuters. The British drugmaker said it has a total capacity sourced for one billion doses through 2020 and into 2021, and continues to increase capacity further.